HRS9531placebo

DRUG2 trials

Sponsors

Fujian Shengdi Pharmaceutical Co., Ltd.

Conditions

Bstructive Sleep Apnea (OSA) and ObesityObese Subjects With Polycystic Ovary Syndrome (PCOS)

Phase 2

A Multicenter, Randomized, Double-blind, Placebo-parallel-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of HRS9531 Injection in Obese Subjects With Polycystic Ovary Syndrome

Not yet recruitingNCT06595797

Fujian Shengdi Pharmaceutical Co., Ltd.Obese Subjects With Polycystic Ovary Syndrome (PCOS)

Start: 2024-09-30End: 2025-12-31Target: 144Updated: 2024-09-19

Phase 3

A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity

RecruitingNCT06974851

Fujian Shengdi Pharmaceutical Co., Ltd.Bstructive Sleep Apnea (OSA) and Obesity

Start: 2025-07-25End: 2026-12-31Target: 140Updated: 2025-11-17